LGND
Ligand Pharmaceuticals Inc
Price:  
114.58 
USD
Volume:  
52,056.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

LGND Fair Value

-249.50 %
Upside

What is the fair value of LGND?

As of 2025-07-05, the Fair Value of Ligand Pharmaceuticals Inc (LGND) is -171.29 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 114.58 USD, the upside of Ligand Pharmaceuticals Inc is -249.50%.

Is LGND a good investment?

With the market price of 114.58 USD and our fair value calculation, Ligand Pharmaceuticals Inc (LGND) is not a good investment. Investing in LGND stocks now will result in a potential loss of 249.50%.

Note: valuation result may not be accurate due to the company's negative EPS.

114.58 USD
Stock Price
-171.29 USD
Fair Price
FAIR VALUE CALCULATION

LGND Fair Value

Peter Lynch's formula is:

LGND Fair Value
= Earnings Growth Rate x TTM EPS
LGND Fair Value
= 25.00 x -6.85
LGND Fair Value
= -171.29

The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings
2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31 5Y Avg
Net income -3.00 57.10 -33.40 52.00 -4.03 13.73
YoY growth -100.48% 2,003.33% -158.49% 255.69% -107.75% 378.46%

LGND Fair Value - Key Data

Market Cap (mil) 2,210.25
P/E
Forward P/E 822.72x
EPS -6.85
Avg earnings growth rate 378.46%
TTM earnings -132.17